Refsum syndromeG60.1

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 28.01.2022

Dieser Artikel auf Deutsch

Synonym(s)

HMSN4; Infantile refsum disease; OMIM-266500; Phytanic acid thesaurism; polyneuritiform hereditary disease

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Refsum, 1949

DefinitionThis section has been translated automatically.

Very rare. autosomal recessive inherited disorder in which two forms are distinguished: infantile form (without skin symptoms - not discussed here) and the adult form. A defect in phytanic acid oxidase leads to increased phytanic acid levels in the serum, to phytanic acid deposits in the liver, kidneys, brain and skin.

EtiopathogenesisThis section has been translated automatically.

Clinical picture which clinically belongs to the vulgar ichthyoses with further characteristics (see below ichthyoses).

Described for adult forms are:

  • mutations of the PHYH-gene (PAHX-gene), which is mapped on chromosome 10pter-p11.2 and causes a defect of the phytanoyl-CoA hydroxylase
  • and
  • Mutations of the PEX7 gene (gene locus: 6q22-q24) with consecutive defect of peroxisomal biogenesis factor-7 (peroxin-7).

The enzyme defect leads to an accumulation of phytanic acid, a saturated, branched-chain fatty acid, which is ingested exclusively with food (especially in meat from ruminants). Phytanic acid is not directly metabolized in the healthy organism by mitochondrial or peroxisomal β-oxidation but it is degraded via the so-called peroxisomal alpha-oxidation by the enzyme phytanoyl-CoA hydroxylase.

The defective enzyme is either phytanoyl-CoA hydroxylase itself or peroxin-7, the transport protein responsible for the transport of phytanol-CoA hydroxylase into the peroxisomes.

The result is an accumulation of phytanic acid in the serum and in various tissues, including the nuclei. The result is an accumulation of phytanic acid in serum and in various tissues, including keratinocytes (detection of lipid vacuoles in keratinocytes).

ManifestationThis section has been translated automatically.

First manifestation in children >10 years); also possible in older adults.

Clinical featuresThis section has been translated automatically.

  • In some patients clinical picture of a (mild) classical vulgar ichthyosis (see below ichthyosis; see also ichthyosis vulgaris, autosomal dominant) with palmoplantar keratoses of different severity, also ichthyotic erythroderma.
  • Extracutaneous manifestations: polyneuritis, paresis mainly in the distal part of the legs and arms, retinitis pigmentosa, night blindness, papilledema, cerebellar ataxia, anosmia.

LaboratoryThis section has been translated automatically.

Liquor protein reproduction with normal cell count.

HistologyThis section has been translated automatically.

Signs of orthhyperkeratosis with reduced or missing Str. granulosum (characteristics of ichthyosis vulgaris). Lipid-containing vacuoles in the keratinocytes.

TherapyThis section has been translated automatically.

Under a diet low in phytanic acid (e.g. no green vegetables, dairy products) improvement of symptoms.

Progression/forecastThis section has been translated automatically.

Good influenceability through diet. Sudden deaths were observed.

LiteratureThis section has been translated automatically.

  1. Budden SS et al (1986) Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children. J Pediatr 108: 33-39
  2. Choksi V et al (2003) Infantile refsum disease: case report. AJNR Am J Neuroradiol 24: 2082-2084
  3. Refsum S, Solomon Islands L, Skatvedt M (1949) Heredopathia atactica polyneuritiformis in children. J Pediat 35: 335-343
  4. Sá MJ et al (2015) Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels. JIMD Rep PubMed PMID: 26303611.

Authors

Last updated on: 28.01.2022